Conexeu Sciences Inc. (NASDAQ:CNXU – Get Free Report) saw a significant increase in short interest in the month of May. As of May 29th, there was short interest totaling 21,639 shares, an increase of ∞ from the May 14th total of 0 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily volume of 31,620 shares, the short-interest ratio is presently 0.7 days.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen upgraded Conexeu Sciences to a “hold” rating in a research note on Saturday, May 30th.
Check Out Our Latest Analysis on CNXU
Conexeu Sciences Trading Down 13.0%
About Conexeu Sciences
Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. — Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property (“IP”) developed over more than a decade at the University of British Columbia (the “University”) and the BC Professional Firefighters Burn and Wound Healing Laboratory.
Further Reading
- Five stocks we like better than Conexeu Sciences
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Conexeu Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conexeu Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
